This special edition opens with a spotlight on the 60-year jubilee of the Standing Committee of European Doctors (CPME). Our organisation was founded in Amsterdam on 23 October 1959 and was joined from its earliest meetings by the National Medical Associations of those countries with applications to join the European Economic Community. Today CPME represents […]

On 10 October 2019, the CPME Executive Committee adopted the ’CPME consultation response on evaluation of Services of General Economic Interest (SGEI) rules applicable to health and social services and the SGEI de minimis Regulation’ (CPME 2019/092 FINAL).

Today, 10 October 2019, CPME released a new short video on alcohol labelling together with the United European Gastroenterology (UEG), the European Alcohol Policy Alliance (Eurocare) and the European Association for the Study of the Liver (EASL). The video shows that it is time for detailed government-monitored alcohol labelling to become an EU-wide regulation. Consumers […]

The European Commission has opened a Call for expression of interest for Expert Panels on Medical Devices and in vitro Diagnostic Medical Devices. The selected experts will provide consistent scientific, technical and/or clinical advice concerning the implementation of the new Regulation (EU) 2017/745 on medical devices (MDR). Your expertise would ensure that high-risk medical devices […]

On 12 September 2019, the CPME Executive Committee adopted the ‘CPME comments on ICH guideline E8 (R1) on general considerations for clinical studies – Step b’ (CPME 2019/072).

This newsletter edition opens with a spotlight on artificial intelligence with three articles presenting different perspectives. In particular, the Director General of DG CONNECT (Directorate General of Communication, Networks, Content and Technology), Mr Roberto Viola, will present the current situation of AI policy at European level. You will find updates on CPME policy developments about […]

On 6 April 2019, the CPME Board adopted the “CPME response to public consultation on EU Regulatory Science to 2025” (CPME 2019/017).

On 6 April 2019, the CPME Board adopted the “CPME comments on the HMA-EMA joint taskforce’s recommendations on Big Data” (CPME 2019/021)

On 6 April 2019, the CPME Board adopted the “CPME response to public consultation on key principles for electronic product information for human medicines in the EU” (CPME 2019/045)

“British medicine is European medicine. We want to keep our British colleagues on board. CPME remains convinced that there are technical and legal solutions to enable doctors’ mobility and cooperation on health post-Brexit. We therefore appeal to negotiators on both sides to show the political willingness to protect health, with pragmatic and sustainable agreements.” Prof. […]